Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 18
Item hits:
Issue DateTitleAuthor(s)
15-Oct-2016Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary FibrosisRussell, AM; Maher, TM; All authors; National Institute for Health Research
18-Apr-2016Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosisRussell, AM; Adamali, H; Molyneaux, PL; Lukey, PT; Marshall, RP, et al
21-Apr-2016Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosisKreuter, M; Wijsenbeek, MS; Vasakova, M; Spagnolo, P; Kolb, M, et al
12-Mar-2016Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease?Byrne, AJ; Maher, TM; Lloyd, CM; Wellcome Trust
21-Apr-2016Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFMercer, PF; Woodcock, HV; Eley, JD; Plate, M; Sulikowski, MG, et al
31-Mar-2016Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysisKreuter, M; Wuyts, W; Renzoni, E; Koschel, D; Maher, TM, et al
8-Mar-2016Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisEvans, IC; Barnes, JL; Garner, IM; Pearce, DR; Maher, TM, et al
16-Nov-2016Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisAlton, EW; Beekman, JM; Boyd, AC; Brand, J; Carlon, MS, et al
5-Oct-2016Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosisKreuter, M; Bonella, F; Maher, TM; Costabel, U; Spagnolo, P, et al
14-Oct-2016Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predictedWard, K; Spurr, L; Goldman, NR; Margaritopoulos, GA; Kokosi, M, et al